Dr. Sanja Stanojevic, Dalhousie University, Halifax, NS

Pulmonary function tests (PFTs) are important for the diagnosis, management and monitoring of disease. At the onset of the COVID-19 pandemic, PFT laboratories around the world cancelled services or significantly scaled down services to reduce the potential risk of transmission. However, it was quickly recognized that services needed to urgently resume, and to resume safely. The CTS and CSRT convened a working group to review available evidence and reach a consensus on recommendations for the resumption of services during the post-peak phase of the pandemic. This talk will highlight the considerations of the working group, summarize the rationale for the recommendations, and discuss what the future of PFTs might look like.

Learning Objectives
At the end of this presentation, attendees will be able to:

  • Understand the factors that contribute to the potential increased risk of COVID-19 transmission in the PFT laboratory;
  • Describe strategies to reduce the risk of transmission within the PFT laboratory; and
  • Be able to consider the CTS/CSRT recommendations for resumption of PFT services within their local context.